SK Bioscience Snaps Up IDT Biologika To Accelerate Growth

'Perfect Fit', New Capabilities

 
• By Jung Won Shin
  
Jae-Yong Ahn, CEO of SK Bioscience
IDT Acquisition To Bring New Capabilities, SK Bioscience CEO Jae-Yong Ahn says • Source: SK Bioscience
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business